As provinces continue their plans for reopening, many organizations are hoping that the future of workplace safety during the pandemic lies in antibody testing. To help you understand what we can expect from testing and what it will mean to community and workplace immunity, we are continuing our series of short, 30-minute webinars.
On July 30th, we welcome Dr. Steven Drews, a University of Alberta researcher and Associate Director of Microbiology at Canadian Blood Services, to the series. Dr. Drews is the team-lead in a year-long serology study looking at the quality of antibodies in those infected with COVID-19. In support of this work, both Dr. Drews and Canadian Blood Services were awarded more than $1 million by Alberta Innovates and the Canadian Institutes of Health Research to support the study.
During the 30-minute session, Dr. Drews will explore:
- What we know now about COVID-19 antibodies
- The study currently underway to better understand COVID-19 immunity
- The implications for testing, economic revitalization and public health
We will also highlight how Medical Confidence’s My Health MaP’s Return to Workplace solution supports organizations in managing their COVID-19 health and safety requirements. We conclude the session with time for questions from the audience.